News Sentiment

PCVX sentiment intelligence

Vaxcyte Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 58.21 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-0.3% over one week, +22.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Vaxcyte (NASDAQ: PCVX) adds independent director John Markels, sets $430,000 equity grant

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction -0.3% Price digesting
Trend fit Trend inactive 22.7% over four weeks
Fair value -4.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 40
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 15
Market source 9
Simply Wall Street 4
simplywall.st 4
DirectorsTalk Interviews 3
Finviz 3
www.marketscreener.com 3
TradingView 2

Event Lens

What the news is about

Classified themes
Market update 43
Earnings 13
Balance sheet 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-59 of 59